Follow The Filings

ONCY Oncolytics Biotech

Oncolytics Biotech earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ONCY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ONCY insider trades
  • $363K bought by 10 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. James T. Parsons Director
    Buy
    $10K 10,000 shares at $1.03 +31% to stake
    Traded Mar 11 Filed Mar 13
    ↗
  2. Jared Kelly CEO
    Buy
    $4,848 5,050 shares at $0.9600 +4.6% to stake
    Traded Mar 12 Filed Mar 13
    ↗
  3. Bernd R. Seizinger Director
    Buy
    $83K 100,000 shares at $0.8300 +21% to stake
    Traded Feb 11–12 Filed Feb 13
    ↗
  4. Wayne Pisano Director
    Buy
    $25K 30,000 shares at $0.8400 +6.5% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  5. Kirk Look CFO
    Buy
    $10K 12,000 shares at $0.8400 +4.4% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  6. Jared Kelly CEO
    Buy
    $30K 35,100 shares at $0.8400 +48% to stake
    Traded Feb 11–12 Filed Feb 13
    ↗
  7. Thomas Charles Heineman Chief Medical Officer
    Buy
    $10K 12,132 shares at $0.8300 +4.5% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  8. Allison Hagerman VP, Product Development
    Buy
    $8,298 10,000 shares at $0.8300 +9.5% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  9. Deborah Margaret Brown Director
    Buy
    $21K 25,000 shares at $0.8500 +30% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  10. Andrew Aromando Chief Business Officer
    Buy
    $25K 29,600 shares at $0.8600 +116% to stake
    Traded Feb 11 Filed Feb 13
    ↗
  11. Patricia S Andrews Director
    Buy
    $30K 35,400 shares at $0.8600 +83% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  12. Bernd R. Seizinger Director
    Buy
    $104K 100,000 shares at $1.04 +27% to stake
    Traded Jan 16 Filed Jan 20
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 3.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 4.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 5.02,8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,3.03,5.02,5.03,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.